Ozmosi | GASTRIN-17 Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

GASTRIN-17

Alternative Names: gastrin-17
Clinical Status: Inactive
Latest Update: 2025-03-11
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Beijing Hospital
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ChiCTR2400079988

 ChiCTR2400079988

N/A

Not yet recruiting

Gastrointestinal Cancer

2027-12-31

2024-01-18

Treatments

ChiCTR2500112900

 ChiCTR2500112900

N/A

/Completed

Gastritis

2025-12-31

ChiCTR2200060018

 ChiCTR2200060018

N/A

Recruiting

Gastrointestinal Cancer

2022-12-29

2023-03-06

Treatments

ChiCTR1900027741

 ChiCTR1900027741

N/A

Recruiting

Gastrointestinal Cancer

2020-12-31

Recent News Events

Date

Type

Title

06/01/2024

PubMed

 Enhancing gastric cancer early detection: A multi-verse optimized feature selection model with crossover-information feedback.

05/04/2024

PubMed

 Diagnostic value of combined detection of three gastric functions and Helicobacter pylori typing in chronic gastritis and gastric cancer.

04/26/2024

PubMed

 Meta-analysis of modified Sijunzi decoction for the treatment of chronic atrophic gastritis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions